Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
SZSE:002864
Operating Income
Forecast
For the last 9 years the
compound annual growth rate for
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's operating income is
10%.
The projected
CAGR
for the next 1 year is
119%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's stock price target?
Not Available
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd doesn't have any price targets made by Wall Street professionals.
What is Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's Revenue forecast?
Projected CAGR
86%
For the last 9 years the
compound annual growth rate for
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's revenue is
16%.
The projected
CAGR
for the next 1 year is
86%.
What is Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's Operating Income forecast?
Projected CAGR
119%
For the last 9 years the
compound annual growth rate for
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's operating income is
10%.
The projected
CAGR
for the next 1 year is
119%.
What is Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's Net Income forecast?
Projected CAGR
81%
For the last 9 years the
compound annual growth rate for
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's net income is
12%.
The projected
CAGR
for the next 1 year is
81%.
